Taiwan FDA registration eb6d858129f4378d181ce1e592744a3f
"Nobel" Letherwave nucleic acid purification test set (unsterilized)
TW: "諾貝爾"列特波核酸純化試藥組(未滅菌)
Taiwan·Risk Class 1·TAIGEN BIOSCIENCE CORPORATION·Registered Mar 04, 2011 – Mar 04, 2016CancelledRegistration details
- Analysis ID
- eb6d858129f4378d181ce1e592744a3f
Company information
- Manufacturer
- TAIGEN BIOSCIENCE CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIGEN BIOSCIENCE CORPORATION
Product details
- Intended Use
- Limited to the first level identification scope of "General Purpose Reaction Reagents (B.4010)" under the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4010 Reaction Reagents for General Purposes
- Import Information
- Domestic
Dates and status
- Registration Date
- Mar 04, 2011
- Expiry Date
- Mar 04, 2016
- Cancellation Date
- Jun 26, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Nobel" Letherwave nucleic acid purification test set (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number eb6d858129f4378d181ce1e592744a3f and manufactured by TAIGEN BIOSCIENCE CORPORATION. The authorized representative in Taiwan is TAIGEN BIOSCIENCE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices